ACGA
ABBV icon

Atlanta Consulting Group Advisors’s AbbVie ABBV Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
13,055
+9,850
+307% +$2.12M 0.52% 34
2026
Q1 		$697K Buy
3,205
+580
+22% +$129K 0.15% 77
2025
Q4 		$600K Sell
2,625
-693
-21% -$158K 0.14% 81
2025
Q3 		$768K Buy
3,318
+151
+5% +$30.7K 0.19% 63
2025
Q2 		$588K Buy
3,167
+1,609
+103% +$299K 0.16% 66
2025
Q1 		$326K Buy
1,558
+380
+32% +$73.9K 0.1% 90
2024
Q4 		$209K Sell
1,178
-3,882
-77% -$714K 0.08% 124
2024
Q3 		$999K Buy
+5,060
New +$944K 0.25% 77

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atlanta Consulting Group Advisors's ABBV Position: Q2 2026 in Review

Atlanta Consulting Group Advisors increased its AbbVie (ABBV) stake by 307% in Q2 2026, buying an estimated $2.12M and bringing the position to 13,055 shares worth $3.29M. The position accounts for 0.52% of the portfolio, ranked #34.

Atlanta Consulting Group Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atlanta Consulting Group Advisors held 13,055 shares of AbbVie worth $3.29M as of Q2 2026.
  • Atlanta Consulting Group Advisors bought 9,850 AbbVie shares in Q2 2026, an estimated $2.12M.
  • AbbVie made up 0.52% of Atlanta Consulting Group Advisors's portfolio in Q2 2026, its #34 holding.
  • Atlanta Consulting Group Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.